Novo Nordisk A/S Common Stock (NVO)
Net Income Growth
-20.81%
Quarterly · Period ending:
NVO Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-20.81%period ending
Latest reported-20.81%period ending
NVO Quarterly Net Income YoY % (-10.67% → -20.81%)
Year-over-year change
High-resolution chart · PNG
NVO net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| -20.8052% | |
| 67.2419% | |
| -4.7432% | |
| -26.7206% | |
| 32.1845% | |
| 14.2756% | |
| 28.5344% | |
| 21.4565% | |
| 3.2016% | |
| 28.2275% | |
| 61.5877% | |
| 56.043% | |
| 45.8778% | |
| 39.437% | |
| 24.7888% | |
| 18.8629% | |
| 9.8573% | |
| 12.5723% | |
| 16.892% | |
| 17.683% | |
| 14.0988% | |
| 6.1024% | |
| 6.8946% | |
| 1.0202% | |
| 10.7348% | |
| 13.9014% | |
| 2.5891% | |
| 12.8029% | |
| -7.2319% | |
| -2.8462% | |
| 2.9565% | |
| -7.5026% | |
| 3.9393% | |
| 5.8586% | |
| -5.127% | |
| -0.3366% | |
| -0.1705% | |
| 7.4141% | |
| 5.3403% | |
| 16.939% | |
| 19.4774% | |
| -4.2629% | |
| 26.4819% | |
| 28.9692% | |
| 19.288% | |
| 52.9266% | |
| 7.8639% | |
| 1.325% | |
| 3.861% | |
| 7.9572% | |
| 5.1781% | |
| 13.1992% | |
| 25.9633% | |
| 28.259% | |
| 22.7341% | |
| 34.8965% | |
| 29.3179% | |
| 14.5102% | |
| 18.8292% | |
| 17.1827% | |
| 16.5163% | |
| 22.5331% | |
| 69.8666% | |
| 30.127% | |
| 18.6225% | |
| 23.1567% | |
| -1.5019% | |
| 3.4159% | |
| 20.9015% | |
| 23.8073% | |
| 137.4784% | |
| 22.0196% | |
| -32.2691% | |
| 27.6511% | |
| -42.39% | |
| 22.9057% | |
| 109.263% | |
| 40.8174% | |
| 44.6587% | |
| 1.5488% | |
| 3.8852% | |
| -1.3954% | |
| -17.2568% | |
| 42.5884% | |
| 31.9288% | |
| 15.0072% | |
| 5.7156% | |
| 8.201% | |
| -0.3922% | |
| -1.6667% | |
| 16.9226% | |
| 13.3453% | |
| 51.3338% | |
| 12.8645% | |
| 14.3489% | |
| -4.9948% | |
| 0.2008% | |
| -5.7126% | |
| 63.6818% | |
| -39.6764% |